rs149629686
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 1P and 7B. PP2BP4_ModerateBP6BS2
The NM_133433.4(NIPBL):c.2603G>A(p.Arg868Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000172 in 1,613,456 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. R868R) has been classified as Likely benign.
Frequency
Consequence
NM_133433.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NIPBL | NM_133433.4 | c.2603G>A | p.Arg868Gln | missense_variant | 10/47 | ENST00000282516.13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NIPBL | ENST00000282516.13 | c.2603G>A | p.Arg868Gln | missense_variant | 10/47 | 1 | NM_133433.4 | P1 | |
NIPBL | ENST00000448238.2 | c.2603G>A | p.Arg868Gln | missense_variant | 10/46 | 1 | |||
NIPBL | ENST00000652901.1 | c.2603G>A | p.Arg868Gln | missense_variant | 10/46 | ||||
NIPBL | ENST00000504430.5 | n.2223G>A | non_coding_transcript_exon_variant | 6/8 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.000165 AC: 25AN: 151800Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000255 AC: 64AN: 250696Hom.: 0 AF XY: 0.000280 AC XY: 38AN XY: 135520
GnomAD4 exome AF: 0.000173 AC: 253AN: 1461656Hom.: 0 Cov.: 32 AF XY: 0.000165 AC XY: 120AN XY: 727120
GnomAD4 genome ? AF: 0.000165 AC: 25AN: 151800Hom.: 0 Cov.: 32 AF XY: 0.000162 AC XY: 12AN XY: 74130
ClinVar
Submissions by phenotype
Cornelia de Lange syndrome 1 Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jan 07, 2024 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 868 of the NIPBL protein (p.Arg868Gln). This variant is present in population databases (rs149629686, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with Cornelia de Lange syndrome (PMID: 23254390). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 436007). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on NIPBL protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 17, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2022 | NIPBL: BS1 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 25, 2018 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 09, 2015 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 08, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at